Mr Richard Vellacott Chief Executive Officer
Biologic Technologies
“We are leaders in the fast-growing category of intelligent bioprocessing systems that put all the power of a factory into your own hands. ”
Bio
Richard is co-founder and CEO of Biologic Technologies. We are leaders in the fast-growing category of intelligent bioprocessing systems that “put all the power of a factory into your own hands”. You can engineer factory-ready biology, solve hidden development threats and unlock new business models with Qudos, the first of a new kind of “personal manufacturing” platform. In seven valuable years as interim CEO, deputy CEO, CFO, COO and Company Secretary, Richard was instrumental in growing the gene editing tools business Horizon Discovery Group plc from an emerging private company of £3m revenue in 2012 to a recognised global leader delivering revenue of £60m at a valuation of £350m. Richard delivered one of the most successful ever Life Science listings on AIM raising £68.6m in a heavily oversubscribed IPO at the top of its valuation range within 3 months, fundraisings in the UK and the US, four acquisitions and hostile bid defence. Richard was previously Vice President, Finance at CSR plc, a dual listed FTSE 250 semiconductor company with $1bn of revenues, and a director in Deloitte’s life sciences practice. Richard is a scientist with a first-class degree in biological sciences from Durham University, and a qualified chartered accountant.